IP Library Granted Patent US 11,172,658
Granted Patent B2
US 11,172,658 · App. 15/905,249 · Granted Nov 16, 2021

Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase

Inventors: Carol J. Phelps (Blacksburg, VA); David L. Ayares (Blacksburg, VA)
Assignee: Revivicor, Inc.
A01K67/0276C12N9/2465C12N15/8509A01K2217/075A01K2227/108A01K2267/02A01K2267/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,172,658
App. No.
15/905,249
Granted
Nov 16, 2021
Kind
B2
Abstract

The present invention is a porcine animal, tissue, organ, cells and cell lines, which lack any expression of functional alpha 1,3 galactosyltransferase (alpha1,3GT). These animals, tissues, organs and cells can be used in xenotransplantation and for other medical purposes.

Claims (4)

1. A method for producing a porcine animal lacking expression of galactose alpha1,3-galactose, comprising: (a) exposing a population of porcine cells to Clostridium difficile ( C. difficile ) toxin A; (b) removing porcine cells that have an altered morphology upon exposure to C. difficile toxin A; (c) expanding and maintaining a porcine cell that does not have an altered morphology upon exposure to C. difficile toxin A to produce an expanded population of porcine cells; and (d) producing a porcine animal from one or more cells from the expanded population of porcine cells.

2. The method of claim 1 , wherein porcine cells that have an altered morphology appear rounder as compared to the porcine cell that does not have an altered morphology.

3. The method of claim 1 , wherein the population of porcine cells are on a plate matrix prior to exposure to the C. difficile toxin A.

4. The method of claim 3 , wherein the porcine cells that have an altered morphology are released from the plate matrix upon exposure to the C. difficile toxin A.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2018
From: PHELPS, CAROL J.
To: REVIVICOR, INC.
Reel/Frame 045077/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2018
From: AYARES, DAVID L.
To: REVIVICOR, INC.
Reel/Frame 045077/0500 →